Fortune January 19, 2024
This past open enrollment season, employees around the country decided once again whether they’d stick with their same insurance plan from last year or maybe add on perks like vision, dental, or an FSA. And for a small but growing segment of the U.S. workforce, another health benefit is on offer—psychedelic drugs.
A slowly increasing number of employers—mostly those who’ve experienced the benefits themselves—are giving their employees access to psychedelic-assisted psychotherapy as part of their health plan.
“Depression is a leading cause of disability, absenteeism, and presenteeism in the workplace,” says Dylan Beynon, founder and CEO of Mindbloom, the largest provider of ketamine-assisted therapy in the U.S. The company offers direct-to-patient treatment and works with employers to offer...
Today's Sponsors
Today's Sponsor